Nanogen, Inc. Releases Enterovirus Reagent Employing Newly Patented Hybridization Technology

SAN DIEGO, June 15 /PRNewswire-FirstCall/ -- Nanogen, Inc. (Nasdaq: NGEN - News), developer of advanced diagnostic products, announced today that it has expanded its product portfolio to include the MGB Alert(TM) ENV real-time PCR reagent, designed to detect sequences associated with enteroviruses. Prevalent in summer and fall, enterovirus infections cause a wide spectrum of diseases and are the most common cause of aseptic meningitis.